WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.on behalf of the Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
2.
HendriksP.M., Ho-dac-PannekeetM.M., van GulikT.M., StruijkD.G., PhoaS.S., SieL.Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics.Perit Dial Int1997; 17: 136–43.
3.
HondaK., HamadaC., NakayamaM., MiyazakiM., SherifA.M., HaradaT.Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology.Clin J Am Soc Nephrol2008; 3: 720–8.
4.
ChoiH.Y., KimD.K., LeeT.H., MoonS.J., HanS.H., LeeJ.E.The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.Perit Dial Int2008; 28: 174–82.
5.
AyuzawaN., IshibashiY., TakazawaY., KumeH., FujitaT.Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.Perit Dial Int2012; 32: 159–67.
TejdeM., LinderM., KarsbergM., EkspongA.The use of biocompatible solutions does not prevent development of encapsulating peritoneal sclerosis.Perit Dial Int2010; 30: 112–21.
